Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

Chronic hepatitis B virus (HBV) infection leads to cirrhosis and hepatocellular carcinoma (HCC). Antiviral agents are thought to reduce HCC development, but agents such as lamivudine (LAM) have a high rate of drug resistance. We compared the incidence of HCC in 472 entecavir (ETV)-treated patients a...

Full description

Saved in:
Bibliographic Details
Main Authors: Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, Yuya Seko, Yusuke Kawamura, Hitomi Sezaki, Norio Akuta, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Hiromitsu Kumada
Format: Artigo
Language:English
Published: 2012
Online Access:https://doi.org/10.1002/hep.26180
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.26180
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/hep.26180
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.26180

Similar Items